AR and prostate cancer: Accordingly, whereas knockdown of Id4 supports the development of castration-resistant prostate cancer through constitutive activation of the androgen receptor [223], induced Id4 overexpression in highly malignant prostate cancer cells leads to apoptosis, decreased cell proliferation, migration and reduced tumor growth of subcutaneous xenografts [224].